TGFbeta1 and TGFbeta2 concentrations are elevated in Parkinson's disease in ventricular cerebrospinal fluid - PubMed (original) (raw)
TGFbeta1 and TGFbeta2 concentrations are elevated in Parkinson's disease in ventricular cerebrospinal fluid
M P Vawter et al. Exp Neurol. 1996 Dec.
Abstract
Transforming growth factor (TGF)beta plays a role in injury repair in sites surrounding brain injury. The present study tested the hypothesis that TGFbeta1 and TGFbeta2 levels in the postmortem CSF of patients with neurodegenerative disorders would be elevated compared to those in normal subjects. Free TGFbeta1 and total TGFbeta2 were measured by ELISA in postmortem ventricular cerebrospinal fluid (vCSF) of patients with Parkinson's disease (n = 30), Alzheimer's disease (n = 30), multiple sclerosis (n = 15), and schizophrenia (n = 12) and of normal controls (n = 16). In addition, albumin, IgG, and total protein in vCSF were measured. Both TGFbeta1 and TGFbeta2 were significantly different between groups (P < 0.002 and P < 0.001, respectively). Parkinson's disease vCSF showed significant increases in both TGFbeta1 (P = 0.015) and TGFbeta2 (P = 0.012) compared to normal controls. There was a trend for TGFbeta2 to be elevated in Alzheimer's disease and multiple sclerosis vCSFs, which failed to achieve significance. There were no differences between controls and schizophrenics in TGFbeta1 or TGFbeta2. Alzheimer's disease vCSF showed a significant decrease in protein compared to all other groups, which was not related to blood-brain barrier permeability, age, or autolysis differences. Evidence is presented suggesting that some TGFbeta1 may leak into the vCSF from plasma. Autopsy vCSF levels of TGFbeta isoforms were found to be distinctly different from those reported for human serum, especially for TGFbeta2, which is undetectable in plasma. These results indicate that further in vivo studies of TGFbeta2 in the CSF of Parkinson's disease patients are warranted to determine the relationship between clinical status, medication, and TGFbeta2 concentrations.
Similar articles
- Increased levels of neuronal thread protein in cerebrospinal fluid of patients with Alzheimer's disease.
de la Monte SM, Volicer L, Hauser SL, Wands JR. de la Monte SM, et al. Ann Neurol. 1992 Dec;32(6):733-42. doi: 10.1002/ana.410320606. Ann Neurol. 1992. PMID: 1471863 - Total prion protein levels in the cerebrospinal fluid are reduced in patients with various neurological disorders.
Meyne F, Gloeckner SF, Ciesielczyk B, Heinemann U, Krasnianski A, Meissner B, Zerr I. Meyne F, et al. J Alzheimers Dis. 2009;17(4):863-73. doi: 10.3233/JAD-2009-1110. J Alzheimers Dis. 2009. PMID: 19542614 - Increased intrathecal TGF-beta1, but not IL-12, IFN-gamma and IL-10 levels in Alzheimer's disease patients.
Rota E, Bellone G, Rocca P, Bergamasco B, Emanuelli G, Ferrero P. Rota E, et al. Neurol Sci. 2006 Apr;27(1):33-9. doi: 10.1007/s10072-006-0562-6. Neurol Sci. 2006. PMID: 16688597 - Cytokines in Parkinson's disease.
Nagatsu T, Mogi M, Ichinose H, Togari A. Nagatsu T, et al. J Neural Transm Suppl. 2000;(58):143-51. J Neural Transm Suppl. 2000. PMID: 11128604 Review. - Challenges in multi-plex and mono-plex platforms for the discovery of inflammatory profiles in neurodegenerative diseases.
Malekzadeh A, de Groot V, Beckerman H, van Oosten BW, Blankenstein MA, Teunissen C. Malekzadeh A, et al. Methods. 2012 Apr;56(4):508-13. doi: 10.1016/j.ymeth.2012.03.017. Epub 2012 Mar 24. Methods. 2012. PMID: 22465283 Review.
Cited by
- Primary cilia in Parkinson's disease: summative roles in signaling pathways, genes, defective mitochondrial function, and substantia nigra dopaminergic neurons.
Tian Z, Zhang Y, Xu J, Yang Q, Hu D, Feng J, Gai C. Tian Z, et al. Front Aging Neurosci. 2024 Sep 18;16:1451655. doi: 10.3389/fnagi.2024.1451655. eCollection 2024. Front Aging Neurosci. 2024. PMID: 39364348 Free PMC article. Review. - Long COVID and its association with neurodegenerative diseases: pathogenesis, neuroimaging, and treatment.
Zhao J, Xia F, Jiao X, Lyu X. Zhao J, et al. Front Neurol. 2024 Apr 4;15:1367974. doi: 10.3389/fneur.2024.1367974. eCollection 2024. Front Neurol. 2024. PMID: 38638307 Free PMC article. Review. - PARK7/DJ-1 in microglia: implications in Parkinson's disease and relevance as a therapeutic target.
Lind-Holm Mogensen F, Scafidi A, Poli A, Michelucci A. Lind-Holm Mogensen F, et al. J Neuroinflammation. 2023 Apr 18;20(1):95. doi: 10.1186/s12974-023-02776-z. J Neuroinflammation. 2023. PMID: 37072827 Free PMC article. Review. - Anti-Inflammatory Effects of Flavonoids in Common Neurological Disorders Associated with Aging.
Martínez-Coria H, Arrieta-Cruz I, Gutiérrez-Juárez R, López-Valdés HE. Martínez-Coria H, et al. Int J Mol Sci. 2023 Feb 21;24(5):4297. doi: 10.3390/ijms24054297. Int J Mol Sci. 2023. PMID: 36901731 Free PMC article. Review. - Molecular Mechanisms Underlying Neuroinflammation Elicited by Occupational Injuries and Toxicants.
Pathak D, Sriram K. Pathak D, et al. Int J Mol Sci. 2023 Jan 23;24(3):2272. doi: 10.3390/ijms24032272. Int J Mol Sci. 2023. PMID: 36768596 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical